PHARMA SYMPOSIUM CANADA Finding the Path to an Accessible and Sustainable Market Towards a New Way of Evaluating Orphan Drugs at CADTH Patients with rare diseases have always felt that orphan drugs should be evaluated differently. Now it appears that public payers are coming around to their point of view. READ MORE >> April 29,…